Boston University
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1839-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bu.edu
Clinical Trials
269
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (219 trials with phase data)• Click on a phase to view related trials
Integrating U=U Into HIV Counseling in South Africa (INTUIT-2.0)
- Conditions
- HIV
- First Posted Date
- 2025-09-30
- Last Posted Date
- 2025-09-30
- Lead Sponsor
- Boston University
- Target Recruit Count
- 880
- Registration Number
- NCT07199634
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
- Conditions
- Systemic SclerodermaDiffuse Cutaneous Scleroderma
- First Posted Date
- 2025-07-29
- Last Posted Date
- 2025-09-30
- Lead Sponsor
- Boston University
- Target Recruit Count
- 65
- Registration Number
- NCT07090226
- Locations
- 🇺🇸
Shapiro Outpatient Rheumatology Clinic at Boston Medical Center, Boston, Massachusetts, United States
HIV Testing in Community Health Center Dental Clinics
- Conditions
- HIV
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- Boston University
- Target Recruit Count
- 6715
- Registration Number
- NCT07089849
- Locations
- 🇺🇸
South End Community Health Center, Boston, Massachusetts, United States
🇺🇸Uphams Corner Health Center, Boston, Massachusetts, United States
🇺🇸East Boston Neighborhood Health, Boston, Massachusetts, United States
Postural Perturbations Tracing to the Stomatognathic System
- Conditions
- Posture
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Boston University
- Target Recruit Count
- 40
- Registration Number
- NCT06974591
- Locations
- 🇺🇸
Goldman School of Dental Medicine, Boston University, Boston, Massachusetts, United States
RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV
- Conditions
- Intimate Partner Violence (IPV)
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-09-19
- Lead Sponsor
- Boston University
- Target Recruit Count
- 172
- Registration Number
- NCT06906302
- Locations
- 🇺🇸
VA Boston Healthcare System, Boston, Massachusetts, United States
🇺🇸VA Minneapolis Healthcare System, Minneapolis, Minnesota, United States
🇺🇸VA Philadelphia Healthcare System, Philadelphia, Pennsylvania, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 54
- Next
News
Novel Royalty-Based Investment Fund Proposes New Model for ALS Drug Development
Researchers from MIT, Massachusetts General Hospital, and Boston University propose a novel "Fund of Adaptive Royalties" (FAR) that finances half the cost of adaptive platform trials in exchange for future drug royalties.
Alzheimer's Drug Discovery Foundation Partners with Siemens Healthineers to License SpeechDx Dataset for Speech-Based Biomarker Development
The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator has partnered with Siemens Healthineers to license the SpeechDx dataset, marking the first commercial partnership for this gold-standard speech and clinical data collection.
American Heart Association Awards $1M to Study GLP-1 Medications' Impact on Cardiovascular Risk
The American Heart Association has funded seven research projects with $1 million to identify which patients with obesity and cardiovascular disease benefit most from GLP-1/GIP medications.